CHMA1004 dihydrochloride

Overview

CHMA1004 (Methyl piperazine-2-carboxylate; METTL3 activator-1) dihydrochloride is a METTL3/METTL14/WTAP methyltransferase complex activator. CHMA1004 dihydrochloride exhibits neuroprotective and anxiolytic potential by enhancing m 6 A methylation modification of RNA. CHMA1004 dihydrochloride promotes HIV replication in an infection context. CHMA1004 dihydrochloride can be used in studies related to anxiety disorders and HIV-1 infection .

Application

Products | Products > Disease Areas > Sexually Transmitted Disease | Products > Disease Areas > Anxiety or Fear-Related Disease | Products > Disease Areas > HIV-1 Infection | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > HIV Infection | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Neurological Disease | Products > Research Areas > Infection | Products > Signaling Pathways > METTL3 | Products > Signaling Pathways > HIV

Product Information

• Catalog No.: HY-W037893
• CAS No.: 122323-88-0
• Molecular Formula: C6H14Cl2N2O2
• Molecular Weight: 217.09
• Purity: 99.38%
• Storage: Store at room temperature, keep dry and cool. In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: ≥ 5 mg/mL (23.03 mM); Clear solution
• Availability: In-stock

Source

Original product source